Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma

被引：3
作者：
Ribas, C
Colleoni, G
Almeida, M
Duch, CR
Ohashi, C
Segreto, R
Silva, MR
机构：
[1] Univ Fed Sao Paulo, EPM, Dept Hematol & Hemotherapy, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, EPM, Dept Radiotherapy, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, EPM, Dept Pathol, Sao Paulo, Brazil
来源：
ACTA ONCOLOGICA | 2004年 / 43卷 / 02期
关键词：
D O I：
10.1080/02841860310021536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 6 条
  • [1] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
    Barlogie, B
    Desikan, R
    Eddlemon, P
    Spencer, T
    Zeldis, J
    Munshi, N
    Badros, A
    Zangari, M
    Anaissie, E
    Epstein, J
    Shaughnessy, J
    Ayers, D
    Spoon, D
    Tricot, G
    [J]. BLOOD, 2001, 98 (02) : 492 - 494
  • [2] Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas
    Bladé, J
    Perales, M
    Rosiñol, L
    Tuset, M
    Montoto, S
    Esteve, O
    Cobo, F
    Villela, L
    Rafel, M
    Nomdedeu, B
    Montserrat, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 422 - 424
  • [3] Solitary plasmacytoma of bone and extramedullary plasmacytoma
    Dimopoulos, MA
    Kiamouris, C
    Moulopoulos, LA
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) : 1249 - +
  • [4] Low-dose thalidomide in myeloma: Efficacy and biologic significance
    Durie, BGM
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 34 - 38
  • [5] Prognostic value of angiogenesis in solitary bone plasmacytoma
    Kumar, S
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Lust, JA
    Wellik, L
    Witzig, TE
    Gertz, MA
    Kyle, RA
    Greipp, PR
    Rajkumar, SV
    [J]. BLOOD, 2003, 101 (05) : 1715 - 1717
  • [6] Wechalekar AD, 2001, BLOOD, V98, p162A
1